markdown

Company Research Report: EKF Diagnostics Holdings plc

Company Overview

Name: EKF Diagnostics Holdings plc

Mission: To improve global healthcare by providing innovative solutions that empower medical professionals and enhance patient outcomes.

Founded: No information is available.

Key People: Gavin Jones, Chief Product Officer.

Headquarters: Penarth, near Cardiff, UK

Number of Employees: No information is available.

Revenue: £52.6 million in 2023

Recognition: Known for its development, production, and distribution of innovative medical technologies and patient-centric solutions, particularly in point-of-care diagnostics and life sciences.

Products

Point-of-Care Diagnostics

EKF develops and manufactures point-of-care in-vitro diagnostic devices and tests to deliver rapid results near a patient's location, enabling quick medical decisions.

1. Diabetes Care

Biosen C-Line: Measures glucose and lactate levels using enzymatic sensor technology for precise results, vital for diabetes management and sports performance analysis.

Quo-Test® and Quo-Lab®: Analyzers for HbA1C measurement.

2. Hematology

DiaSpect Tm, Hemo Control, HemataStat II™: Hemoglobin analyzers for blood diagnostics, improving diagnostics, blood donation, and anemia tests.

3. Connectivity

EKF Link: Middleware for real-time data and device management by connecting devices to IT systems.

4. Women’s Health

Creamatocrit Plus™ and Pregnancy Tests: Analyzers for assessing lipid content in mother's milk and pregnancy testing.

5. Sports Performance

Lactate Scout Sport: Measures lactate levels for optimized sports training and performance.

6. Veterinary Care

Lactate Scout Vet, Hemo Vet: Analyzers for lactate, hemoglobin, and hematocrit for veterinary diagnostics.

Life Sciences

EKF supplies reagents, enzymes, and components supporting research, biotech, and pharma industries.

Precision Fermentation: Facilities designed for scaling biomaterial fermentation processes.

Custom Bioprocessing: Offers solutions to meet dynamic healthcare needs.

Diagnostic Enzymes: Includes products like Arylacylamidase, Beta-Hydroxybutyrate Dehydrogenase, and Salicylate Hydroxylase.

Central Laboratory

Provides high-throughput, accurate testing solutions in central labs.

Reagents and Immunoassays: Includes Beta-Hydroxybutyrate LiquiColor®, RaPET® rapid tests.

Infectious Diseases Testing: Rapid detection of agents like Group A Streptococcal Antigen (QuStick™).

Occult Blood Testing: Aids early colorectal cancer detection (Hema-Screen®).

Recent Developments

Launch of Biosen C-Line Analyzer: An advanced benchtop glucose and lactate analyzer enhancing user experience with touchscreen and improved connectivity. It is compliant with EU IVDR regulations and can run 120 samples per hour, delivering results quickly, making it suitable for diabetes management and sports applications.

Participation in Global Events:

Medlab Middle East 2025: EKF will showcase diagnostic solutions at this event in Dubai.

Medica 2024: Participation in Düsseldorf to showcase point-of-care solutions.

AABB 2024: Engagement in Houston with the biomedical community.

New Facilities: Opening of a state-of-the-art life sciences facility in October 2023, enhancing the ability to support innovative biotechnology solutions.